Breaking Barriers in Mental Health: How Psychedelic Therapy Can Reduce Human Suffering

Living Medicine

Sherry Rais is the Co-founder and CEO of Enthea, a licensed, third-party administrator of health plan benefits. Through her company, she focuses on expanding access to psychedelic-assisted therapy to alleviate human suffering. Sherry holds a Certificate in Psychedelic Therapies and Research and is the former Executive Director of the Boston Psychedelic Research Group.

In this episode…

The world is riddled with suffering, and it’s often linked to natural disasters, community tragedies, and poverty. How can we alleviate human suffering and help individuals work through their traumas?

Psychedelics advocate Sherry Rais maintains that certain levels of suffering and discomfort are crucial to personal growth and transformation. Individuals can recognize and confront their adversities through ketamine-assisted psychotherapy, which allows people to relive their trauma in controlled environments with licensed professionals guiding them through the treatment experience. However, access to these groundbreaking therapies remains limited, so Sherry works with employers to integrate psychedelic-assisted psychotherapy treatments with healthcare plans, forming a path to alternative methods for reducing suffering.

In today’s episode of Living Medicine, Sherry Rais, the Co-founder and CEO of Enthea, joins Dr. Sandy Newes to discuss leveraging ketamine-assisted therapy to alleviate human suffering. Sherry talks about the various types of human suffering, how to advance the psychedelic-assisted therapy field, and the qualities of a cutting-edge psychedelic therapy training program.